Suppr超能文献

人体免疫血清对溶组织内阿米巴半乳糖或N - 乙酰半乳糖胺结合凝集素的识别。

Recognition of the galactose- or N-acetylgalactosamine-binding lectin of Entamoeba histolytica by human immune sera.

作者信息

Petri W A, Joyce M P, Broman J, Smith R D, Murphy C F, Ravdin J I

机构信息

Department of Internal Medicine, University of Virginia School of Medicine, Charlottesville 22908.

出版信息

Infect Immun. 1987 Oct;55(10):2327-31. doi: 10.1128/iai.55.10.2327-2331.1987.

Abstract

Cure of amebic liver abscess is associated with resistance to recurrent invasive amebiasis and the development of a humoral and cell-mediated immune response. We determined whether human immune sera contain blocking antibody for the 170-kilodalton (kDa) galactose or N-acetylgalactosamine (Gal/GalNAc)-binding lectin of Entamoeba histolytica. By Western blot (immunoblot) of whole amebae subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis, all eight immune sera studied here prominently recognized a 170-kDa amebic protein. Western blot of the purified Gal/GalNAc lectin with pooled human immune sera (PHIS) confirmed that the 170-kDa band was the adherence lectin. Immunoprecipitation of [35S]methionine-metabolically-labeled amebae with the antilectin monoclonal antibody H8-5 and with PHIS demonstrated that the 170-kDa lectin was the major antigen recognized by PHIS. The in vitro adherence of E. histolytica trophozoites to CHO cells at 4 degrees C was inhibited by prior exposure of amebae to greater than or equal to 1.0% PHIS. The humoral response to the Gal/GalNAc-binding lectin of the parasite may contribute to the development of protective immunity against invasive amebiasis.

摘要

阿米巴肝脓肿的治愈与对复发性侵袭性阿米巴病的抵抗力以及体液免疫和细胞介导免疫反应的发展有关。我们确定了人类免疫血清中是否含有针对溶组织内阿米巴170千道尔顿(kDa)半乳糖或N - 乙酰半乳糖胺(Gal/GalNAc)结合凝集素的阻断抗体。通过对经十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳处理的全阿米巴进行蛋白质免疫印迹(免疫印迹),此处研究的所有8份免疫血清均显著识别出一种170-kDa的阿米巴蛋白。用混合人免疫血清(PHIS)对纯化的Gal/GalNAc凝集素进行蛋白质免疫印迹证实,170-kDa条带为粘附凝集素。用抗凝集素单克隆抗体H8-5和PHIS对[35S]甲硫氨酸代谢标记的阿米巴进行免疫沉淀,结果表明170-kDa凝集素是PHIS识别的主要抗原。将阿米巴预先暴露于大于或等于1.0%的PHIS可抑制溶组织内阿米巴滋养体在4℃下对CHO细胞的体外粘附。寄生虫对Gal/GalNAc结合凝集素的体液反应可能有助于针对侵袭性阿米巴病的保护性免疫的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb56/260708/364cde7f7ec8/iai00094-0011-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验